OBike pulls out of Melbourne and enters liquidation in Singapore: Why hasn’t bike-sharing kicked off in Australia? – SmartCompany.com.au

Its safe to say that bike-sharing companies in Australia havent had the smoothest ride over the past 12 months. From unhappy local councils, to Melbournes former Lord Mayor declaring their bikes clutter, and users across the country gleefully dumping bikes in rivers, up trees, and on top of buildings, companies such as oBike and Ofo…

Details

The story of the one time double-glazing salesman who became an international drugs kingpin – Mirror.co.uk

At the height of the mad cow disease scare, from the confines of his prison cell, former “young businessman of the year” Martin Evans came up with an audacious ostrich-meat scam which robbed some pensioners of their life savings. Before he became a drugs kingpin, smuggling millions of pounds worth of cocaine and ecstasy pills…

Details

Regulus Announces Strategic Update and Corporate Restructuring – PR Newswire (press release)

LA JOLLA, Calif., July 5, 2018 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced a strategic update and corporate restructuring. With the goal of extending its cash runway, Regulus has taken the following steps: recruitment activities for the RG-012 clinical…

Details

New hope for Cockatoo Island’s iron ore mine, after two floods and a sale that fell through – ABC News

It’s the iron ore mine that has spent more time under water than in production. The Cockatoo Island mine sits off the remote West Kimberley coast, 2,000km north of Perth. The mine’s main deposit sits below sea level, behind a seawall. Constant maintenance and dewatering is needed to prevent more seawater from seeping in, costing…

Details

Regulus Announces Strategic Update and Corporate Restructuring – BioSpace (press release) (blog)

Efforts Aimed at Extending Cash Runway to mid-2019 LA JOLLA, Calif., July 5, 2018 /PRNewswire/ — Regulus Therapeutics, Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced a strategic update and corporate restructuring. With the goal of extending its cash runway, Regulus has taken the…

Details